Cargando…

Safety of long-term intrathecal methotrexate in progressive forms of MS

BACKGROUND: There are few treatment options for multiple sclerosis (MS) patients with advanced disability [expanded disability status scale (EDSS) ⩾ 6.0]. In 2010, we reported initial results of using intrathecal methotrexate (ITMTX) in patients with progressive MS. We now report on long-term use of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stark, James W., Josephs, Lena, Dulak, Deirdre, Clague, Madison, Sadiq, Saud A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891004/ https://www.ncbi.nlm.nih.gov/pubmed/31832101 http://dx.doi.org/10.1177/1756286419892360

Ejemplares similares

Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis
por: Harris, Violaine K., et al.
Publicado: (2018)

Subacute quadriplegic myelopathy following intrathecal methotrexate
por: Maramattom, Boby Varkey, et al.
Publicado: (2016)

Alemtuzumab and intrathecal methotrexate failed in the therapy of Rasmussen encephalitis
por: Liba, Zuzana, et al.
Publicado: (2017)

Radiation Myelopathy Caused by Palliative Radiotherapy and Intrathecal Methotrexate
por: Fukuda, Yukiko, et al.
Publicado: (2022)

Intrathecal Methotrexate-Induced Posterior Reversible Encephalopathy Syndrome (PRES)
por: Güler, Tülay, et al.
Publicado: (2014)

Methotrexate myelopathy after intrathecal chemotherapy: a case report
por: Murata, Ken-ya, et al.
Publicado: (2015)

Subacute neurological deficits and respiratory insufficiency due to intrathecal methotrexate
por: de Faber, Sjoerd I. P. J., et al.
Publicado: (2021)

Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study
por: Harris, Violaine K., et al.
Publicado: (2020)

Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment
por: Genovese, Mark C, et al.
Publicado: (2019)

Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
por: Weber, Martin S.
Publicado: (2015)

Intrathecal Methotrexate-Induced Aseptic Meningitis in a Patient with Acute Lymphoblastic Leukemia
por: Tang, Wesley, et al.
Publicado: (2022)

Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension
por: Bergman, Joakim, et al.
Publicado: (2020)

Utility and Safety of Intrathecal Methotrexate Treatment in Severe Anti-N-methyl-D-aspartate Receptor Encephalitis: A Pilot Study
por: Yang, Xun-Zhe, et al.
Publicado: (2018)

The Long-Term Safety and Efficacy of Intrathecal Therapy Using Sufentanil in Chronic Intractable Non-Malignant Pain
por: Monsivais, Jose Jesus, et al.
Publicado: (2014)

Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features
por: Tariq, Hamza, et al.
Publicado: (2018)

Effects of natalizumab therapy on intrathecal antiviral antibody responses in MS
por: Largey, Fabienne, et al.
Publicado: (2019)

Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
por: Salliot, C, et al.
Publicado: (2008)

Acute lumbar polyradiculoneuropathy as early sign of methotrexate intrathecal neurotoxicity: Case report and literature review
por: Montejo, Carmen, et al.
Publicado: (2019)

Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis
por: Kang, Xun, et al.
Publicado: (2022)

Myelinodegeneration vs. Neurodegeneration in MS Progressive Forms
por: Nataf, Serge
Publicado: (2023)

Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice
por: Mueller, Andre M., et al.
Publicado: (2013)

Long-term methotrexate efficacy in juvenile localized scleroderma
por: Zulian, F, et al.
Publicado: (2011)

Intrathecal Inflammation in Progressive Multiple Sclerosis
por: Monaco, Salvatore, et al.
Publicado: (2020)

Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients
por: Fleischmann, Roy, et al.
Publicado: (2017)

Evaluation of uptake of the cytostatic methotrexate in Elliptio complanata mussels by LC–MS/MS
por: Poirier Larabie, Sylvie, et al.
Publicado: (2022)

LC-MS metabolomics comparisons of cancer cell and macrophage responses to methotrexate and polymer-encapsulated methotrexate
por: Al-Natour, Mohammad Ahmad, et al.
Publicado: (2019)

Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease
por: Hordeaux, J., et al.
Publicado: (2017)

Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma
por: Cheng, Chieh‐Lung, et al.
Publicado: (2023)

Efficiency and Safety of Aftercare With Intrathecal Baclofen on Location
por: Goslinga‐van der Gaag, Simone M.E., et al.
Publicado: (2019)

Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy
por: Ksouda, Kamilia, et al.
Publicado: (2014)

Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports
por: Meissner, Magdalena, et al.
Publicado: (2016)

Clinical Improvement and Prolonged Survival With High Dose Intrathecal Methotrexate for Carcinomatous Meningitis Secondary to a Lung Adenocarcinoma
por: Clatot, Florian, et al.
Publicado: (2011)

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
por: Bobillo, Sabela, et al.
Publicado: (2021)

SDPS-16 CYTOLOGIC AND SEROLOGIC RESPONSE WITH INTRATHECAL METHOTREXATE IN A PATIENT WITH LEPTOMENINGEAL CARCINOMATOSIS FROM OVARIAN CANCER
por: Cordova, Christine, et al.
Publicado: (2023)

Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
por: Duell, Frida, et al.
Publicado: (2020)

Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS
por: Engel, Sinah, et al.
Publicado: (2020)

Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy
por: Stolte, Benjamin, et al.
Publicado: (2018)

Blessing or burden? Long‐term maintenance, complications and clinical outcome of intrathecal baclofen pumps
por: Chan, David Yuen‐Chung, et al.
Publicado: (2018)

Long-Term Sequela of Intrathecal Gadolinium Extravasation: Symptoms Mimicking Post-concussive Syndrome
por: Patel, Aakaash, et al.
Publicado: (2021)

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial
por: Kremer, Joel M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b7re8e9kd7618hm6jqg7569dto